Study of Post Menopausal Osteoporosis (PMO) Among Gynecology Outpatients in Pakistan
NCT02422069 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 624
Last updated 2016-11-02
Summary
This observational study will provide an opportunity to document local patterns of susceptibility, patient profile, and usefulness of screening in postmenopausal patients coming to gynecology outpatient clinics in Pakistan. This will also capture the initial management of PMO in diagnosed patients. The information gathered will serve as a foundation for developing national guidelines on screening and management of PMO in Pakistan.
Conditions
- Postmenopausal Osteoporosis
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Clinical Trials · Hoffmann-La Roche
Eligibility
- Min Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-04-30
- Primary Completion
- 2011-12-31
- Completion
- 2011-12-31
Countries
- Pakistan
Study Locations
More Related Trials
-
Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors
NCT05590949 ·Status: RECRUITING
-
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
NCT02732210 ·Status: COMPLETED
-
PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE)
NCT00515593 ·Status: COMPLETED
-
Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMO
NCT00577421 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study of Menopausal Symptom in Patients With Gynecological Malignancy After Oophorectomy
NCT06151028 ·Status: RECRUITING
-
Anabolic Therapy in Postmenopausal Osteoporosis
NCT05010590 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Study to Evaluate the Safety and Efficacy of Denosumab and Actonel® in Post Menopausal Women Transitioned From Alendronate Therapy
NCT00919711 ·Status: COMPLETED ·Phase: PHASE3
-
Resolution of Effect of Bisphosphonates on Bone in Postmenopausal Osteoporosis
NCT01406613 ·Status: COMPLETED
-
Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis
NCT01631214 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis
NCT00091793 ·Status: COMPLETED ·Phase: PHASE3
-
Intervention Study of Drugs in Patients Osteopenia and Osteoporosis
NCT04719572 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Romosozumab and Denosumab Combined Treatment in Postmenopausal Osteoporosis Patients with Multiple Fragility Fractures
NCT06720350 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Efficacy of Denosumab Treatment in Bisphosphonate Unresponsive Patients
NCT04702204 ·Status: COMPLETED
-
Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in France
NCT02347865 ·Status: COMPLETED
-
Safety and Efficacy of OSTEOFORM (rhPTH [1-34]) in Increasing Bone Mineral Density in Osteoporosis
NCT00500409 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis
NCT01575834 ·Status: COMPLETED ·Phase: PHASE3
-
Denosumab Safety Assessment in Multiple Observational Databases
NCT02520362 ·Status: COMPLETED
-
Denosumab Biosimilar Injection in Post Menopausal Women With Osteoporosis
NCT05419427 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of LY06006 in Postmenopausal Women With Osteoporosis at High Risk for Fracture
NCT05060406 ·Status: UNKNOWN ·Phase: PHASE3
-
The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine Evaluation
NCT00674453 ·Status: COMPLETED ·Phase: PHASE2
-
A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab
NCT00887965 ·Status: COMPLETED ·Phase: PHASE2
-
Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis
NCT00532337 ·Status: COMPLETED ·Phase: PHASE2
-
Dental Care and Initiation of Anti-osteoporotic Therapy
NCT05719818 ·Status: COMPLETED
-
Risedronate in Postmenopausal Women With Low Bone Density
NCT00351091 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Test the Efficacy, Safety and Tolerability of Romosozumab Treatment in Postmenopausal Chinese Women With Osteoporosis
NCT05067335 ·Status: COMPLETED ·Phase: PHASE3